Eterna Therapeutics
ERNA
#11171
Rank
โ‚ฌ2.09 M
Marketcap
1,24ย โ‚ฌ
Share price
-16.56%
Change (1 day)
2.91%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2026 (TTM): -25,07ย โ‚ฌ

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -26,69ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2.867ย โ‚ฌ an increase over its 2021 EPS that were of -18.945ย โ‚ฌ.

EPS history for Eterna Therapeutics from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-25,07ย โ‚ฌ
2022-2.867ย โ‚ฌ-84.86%
2021-18.945ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
1,81ย โ‚ฌ-106.76%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-1,29ย โ‚ฌ-95.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
1,56ย โ‚ฌ-105.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-0,07291ย โ‚ฌ-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
0,41ย โ‚ฌ-101.54%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
1,07ย โ‚ฌ-103.99%๐Ÿ‡บ๐Ÿ‡ธ USA